Previous Close | 0.6000 |
Open | N/A |
Bid | 0.0000 |
Ask | 3.9000 |
Strike | 30.00 |
Expire Date | 2024-08-16 |
Day's Range | 0.6000 - 0.6000 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript May 9, 2024 Cytokinetics, Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome ladies and gentlemen to Cytokinetics First Quarter 2024 Conference Call. [Operator Instructions] I will now […]
Insights into financial health, R&D progress, and strategic preparations for upcoming FDA submissions.
Cytokinetics (CYTK) delivered earnings and revenue surprises of -14.66% and 26.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?